BlossomHill Therapeutics, Inc.

BLSM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13D Aug 18, 2026
SCHEDULE 13G Aug 17, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13D Aug 13, 2026
4 Aug 12, 2026
4 Aug 12, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
4 Aug 10, 2026
S-8 Aug 10, 2026 S-8
8-K Aug 10, 2026 8-K
424B4 Aug 7, 2026 424B4
EFFECT Aug 6, 2026
3 Aug 6, 2026
3 Aug 6, 2026
3 Aug 6, 2026
3 Aug 6, 2026
3 Aug 6, 2026
3 Aug 6, 2026
← Newer Page 1 of 2 · 41 filings Older →